Original Article
Machine learning prediction of the case-fatality of COVID-19 and risk factors for adverse outcomes in patients with non-small cell lung cancer
Translational Cancer Research
2024;
13
(6)
:2587-2595
.
(30 June 2024)
Extracellular vesicles isolated from curcumin-medium weakened RKO cell proliferation and migration
Translational Cancer Research
2024;
13
(6)
:2596-2604
.
(30 June 2024)
A novel inflammatory nutrient index for predicting survival outcomes in patients with non-small cell lung cancer
Translational Cancer Research
2024;
13
(6)
:2605-2617
.
(30 June 2024)
Naringin inhibits cisplatin resistance of ovarian cancer cells by inhibiting autophagy mediated by the TGF-β2/smad2 pathway
Translational Cancer Research
2024;
13
(6)
:2618-2628
.
(30 June 2024)
Construction and validation of a prognostic and therapeutic cuproptosis- and immune-related gene signature in hepatocellular carcinoma
Translational Cancer Research
2024;
13
(6)
:2629-2646
.
(30 June 2024)
The prognostic value of immune escape-related genes in lung adenocarcinoma
Translational Cancer Research
2024;
13
(6)
:2647-2661
.
(30 June 2024)
Neoadjuvant therapy bridging percutaneous coronary intervention (PCI) and video-assisted thoracoscopic (VATS) lobectomy: a retrospective study
Translational Cancer Research
2024;
13
(6)
:2662-2673
.
(30 June 2024)
Significance of dysregulated M2 macrophage and ESR2 in the ovarian metastasis of gastric cancer
Translational Cancer Research
2024;
13
(6)
:2674-2690
.
(30 June 2024)
Increase in GPIHBP1 expression in advanced stage colorectal cancer indicates poor immune surveillance
Translational Cancer Research
2024;
13
(6)
:2691-2703
.
(30 June 2024)
Construction of a new prognostic model for colorectal cancer based on bulk RNA-seq combined with The Cancer Genome Atlas data
Translational Cancer Research
2024;
13
(6)
:2704-2720
.
(30 June 2024)
Screening of postoperative adjuvant chemotherapy-related serum metabolic markers in breast cancer patients based on 1H NMR metabonomics
Translational Cancer Research
2024;
13
(6)
:2721-2734
.
(30 June 2024)
Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy for resectable esophageal cancer: a systematic review and meta-analysis
Translational Cancer Research
2024;
13
(6)
:2735-2750
.
(30 June 2024)
Development and external validation of a prognostic nomogram to predict survival in patients aged ≥60 years with pancreatic ductal adenocarcinoma
Translational Cancer Research
2024;
13
(6)
:2751-2766
.
(30 June 2024)
SYT7 promotes breast cancer cells growth through the PI3K/AKT pathway
Translational Cancer Research
2024;
13
(6)
:2767-2778
.
(30 June 2024)
Head-to-head comparison of [68Ga]Ga-FAPI-04 PET and [18F]FDG PET in the detection of cancer recurrence: a systematic review and meta-analysis
Translational Cancer Research
2024;
13
(6)
:2779-2789
.
(30 June 2024)
Development of a prediction model for the association between thyroid dysfunction and breast cancer
Translational Cancer Research
2024;
13
(6)
:2790-2798
.
(30 June 2024)
Construction of m7G RNA modification-related prognostic model and prediction of immune therapy response in hepatocellular carcinoma
Translational Cancer Research
2024;
13
(6)
:2799-2811
.
(30 June 2024)
Overexpression of CENPU promotes cancer growth and metastasis and is associated with poor survival in patients with nasopharyngeal carcinoma
Translational Cancer Research
2024;
13
(6)
:2812-2824
.
(30 June 2024)
Prognostic value of GARS in bladder cancer and its role in the tumor microenvironment
Translational Cancer Research
2024;
13
(6)
:2825-2846
.
(30 June 2024)
MFAP2 induces epithelial-mesenchymal transformation of osteosarcoma cells by activating the Notch1 pathway
Translational Cancer Research
2024;
13
(6)
:2847-2859
.
(30 June 2024)
Identification of tumor antigens for mRNA vaccines and ferroptosis-related landscape in esophageal squamous cell carcinoma
Translational Cancer Research
2024;
13
(6)
:2860-2876
.
(30 June 2024)
Value analysis of ITLN1 in the diagnostic and prognostic assessment of colorectal cancer
Translational Cancer Research
2024;
13
(6)
:2877-2891
.
(30 June 2024)
Analysis of methylation-driven genes for predicting the prognosis of patients with oral squamous cell carcinoma
Translational Cancer Research
2024;
13
(6)
:2892-2904
.
(30 June 2024)
The risk and survival of multiple myeloma as the second primary malignancy in a single Chinese center
Translational Cancer Research
2024;
13
(6)
:2905-2912
.
(30 June 2024)
Signature identification based on immunogenic cell death-related lncRNAs to predict the prognosis and immune activity of patients with endometrial carcinoma
Translational Cancer Research
2024;
13
(6)
:2913-2937
.
(30 June 2024)
A signature of four ferroptosis-related genes in laryngeal squamous cell carcinoma
Translational Cancer Research
2024;
13
(6)
:2938-2949
.
(30 June 2024)
Status and development of research on clear cell carcinoma of the ovary—a visualization-based bibliometric analysis
Translational Cancer Research
2024;
13
(6)
:2950-2970
.
(30 June 2024)
Clinicopathological significance of cancer stem cell marker CD44/SOX2 in esophageal squamous cell carcinoma (ESCC) patients and construction of a nomogram to predict overall survival
Translational Cancer Research
2024;
13
(6)
:2971-2984
.
(30 June 2024)
Bioinformatics prediction and experimental verification identify a cuproptosis-related gene signature as prognosis biomarkers of hepatocellular carcinoma
Translational Cancer Research
2024;
13
(6)
:2985-3002
.
(30 June 2024)
Benefits of adjuvant chemotherapy in elderly patients with stage IB–IIIB non-small cell lung cancer: a propensity-matched analysis
Translational Cancer Research
2024;
13
(6)
:3003-3015
.
(30 June 2024)
Retrospective clinical study analysis of skin adverse reactions related to epidermal growth factor receptor inhibitors
Translational Cancer Research
2024;
13
(6)
:3016-3030
.
(30 June 2024)
Synergistic action of gemcitabine and celecoxib in promoting the antitumor efficacy of anti-programmed death-1 monoclonal antibody by triggering immunogenic cell death
Translational Cancer Research
2024;
13
(6)
:3031-3045
.
(30 June 2024)
OIP5-AS1/miR-455-3p/microfibril-associated protein 2 axis exacerbates the progression of thyroid carcinoma
Translational Cancer Research
2024;
13
(6)
:3046-3061
.
(30 June 2024)
ITGAM sustains MAPK signaling and serves as an adverse prognostic factor and therapeutic target in acute myeloid leukemia
Translational Cancer Research
2024;
13
(6)
:3062-3074
.
(30 June 2024)
Combining non-invasive liquid biopsy and a methylation analysis to assess surgical risk for early esophageal cancer
Translational Cancer Research
2024;
13
(6)
:3075-3089
.
(30 June 2024)
Review Article
Exosomal microRNAs in lung cancer: a narrative review
Translational Cancer Research
2024;
13
(6)
:3090-3105
.
(30 June 2024)
Overview of the interplay between m6A methylation modification and non-coding RNA and their impact on tumor cells
Translational Cancer Research
2024;
13
(6)
:3106-3125
.
(30 June 2024)
Ferroptosis: a promising target for fumarate hydratase-deficient tumor therapeutics literature review
Translational Cancer Research
2024;
13
(6)
:3126-3141
.
(30 June 2024)
Involvement of long non-coding RNA LOXL1-AS1 in the tumourigenesis and development of malignant tumours: a narrative review
Translational Cancer Research
2024;
13
(6)
:3142-3155
.
(30 June 2024)
Mechanisms and therapeutic targets of ErbB family receptors in hepatocellular carcinoma: a narrative review
Translational Cancer Research
2024;
13
(6)
:3156-3178
.
(30 June 2024)
Letter to the Editor
Predicting papillary thyroid microcarcinoma in TI-RADS 3 nodules: a combined radiomics and clinical model
Translational Cancer Research
2024;
13
(6)
:3179-3180
.
(30 June 2024)
Retraction
Retraction: inhibitory effect of lovastatin on human lung cancer cell proliferation by regulating the ERK1/2 and COX-2 pathways
Translational Cancer Research
2024;
13
(6)
:3181
.
(30 June 2024)
